$GOSS
Gossamer Bio, Inc.

2019 Q4 Form 10-K Financial Statement

#000156459020012323 Filed on March 24, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.59M $38.24M $13.80M
YoY Change -16.01% -12.59% 8525.0%
% of Gross Profit
Research & Development $42.60M $143.4M $25.87M
YoY Change 64.67% 159.4% 3704.41%
% of Gross Profit
Depreciation & Amortization $290.0K $917.0K $140.0K
YoY Change 107.14% 208.75%
% of Gross Profit
Operating Expenses $54.19M $186.1M $39.81M
YoY Change 36.12% 24.93% 4696.39%
Operating Profit -$55.79M -$186.1M -$39.81M
YoY Change 40.14% 24.93%
Interest Expense $1.938M $690.0K
YoY Change 16050.0% -675.0%
% of Operating Profit
Other Income/Expense, Net $1.090M $5.832M $320.0K
YoY Change 240.63% 188.14%
Pretax Income -$54.70M -$180.3M -$38.79M
YoY Change 41.02% 54.21% 501.4%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$54.70M -$180.3M -$38.79M
YoY Change 41.0% 22.68% 501.46%
Net Earnings / Revenue
Basic Earnings Per Share -$3.29
Diluted Earnings Per Share -$891.6K -$3.29 -$526.5K
COMMON SHARES
Basic Shares Outstanding 66.04M 54.74M shares
Diluted Shares Outstanding 54.74M shares

Balance Sheet

Concept 2019 Q4 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $401.8M $401.8M $228.7M
YoY Change 75.69% 75.69%
Cash & Equivalents $135.0M $135.1M $105.2M
Short-Term Investments $266.7M $266.7M $123.4M
Other Short-Term Assets $7.500M $7.500M $3.300M
YoY Change 127.27% 127.27%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $409.3M $409.3M $232.0M
YoY Change 76.47% 76.42%
LONG-TERM ASSETS
Property, Plant & Equipment $5.425M $15.70M $3.193M
YoY Change 69.9% 390.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.559M $1.600M $4.273M
YoY Change -63.52% -62.79%
Total Long-Term Assets $17.29M $17.30M $7.466M
YoY Change 131.54% 133.78%
TOTAL ASSETS
Total Short-Term Assets $409.3M $409.3M $232.0M
Total Long-Term Assets $17.29M $17.30M $7.466M
Total Assets $426.6M $426.6M $239.4M
YoY Change 78.18% 78.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $956.0K $1.000M $2.182M
YoY Change -56.19% -54.55%
Accrued Expenses $16.71M $36.00M $7.568M
YoY Change 120.78% 97.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $36.92M $36.90M $20.40M
YoY Change 80.97% 80.88%
LONG-TERM LIABILITIES
Long-Term Debt $28.46M $28.50M $0.00
YoY Change
Other Long-Term Liabilities $8.700M $8.700M $700.0K
YoY Change 1142.86% 1142.86%
Total Long-Term Liabilities $28.46M $37.20M $700.0K
YoY Change 3965.57% 5214.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.92M $36.90M $20.40M
Total Long-Term Liabilities $28.46M $37.20M $700.0K
Total Liabilities $74.12M $74.10M $21.12M
YoY Change 250.93% 251.18%
SHAREHOLDERS EQUITY
Retained Earnings -$334.2M -$153.9M
YoY Change 117.21%
Common Stock $686.4M $33.86M
YoY Change 1927.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $352.5M $352.5M -$120.1M
YoY Change
Total Liabilities & Shareholders Equity $426.6M $426.6M $239.4M
YoY Change 78.18% 78.2%

Cashflow Statement

Concept 2019 Q4 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$54.70M -$180.3M -$38.79M
YoY Change 41.0% 22.68% 501.46%
Depreciation, Depletion And Amortization $290.0K $917.0K $140.0K
YoY Change 107.14% 208.75%
Cash From Operating Activities -$44.14M -$144.8M -$25.02M
YoY Change 76.42% 183.74% 336.65%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K $2.966M -$320.0K
YoY Change 65.62% -15.01%
Acquisitions
YoY Change
Other Investing Activities $47.46M -$144.2M -$8.360M
YoY Change -667.7% 2.1%
Cash From Investing Activities $46.94M -$147.1M -$8.680M
YoY Change -640.78% 1.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $291.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.520M $321.6M -2.140M
YoY Change -171.03% 6.89% -135.67%
NET CHANGE
Cash From Operating Activities -44.14M -$144.8M -25.02M
Cash From Investing Activities 46.94M -$147.1M -8.680M
Cash From Financing Activities 1.520M $321.6M -2.140M
Net Change In Cash 4.320M $29.67M -35.84M
YoY Change -112.05% -71.77% -13374.07%
FREE CASH FLOW
Cash From Operating Activities -$44.14M -$144.8M -$25.02M
Capital Expenditures -$530.0K $2.966M -$320.0K
Free Cash Flow -$43.61M -$147.8M -$24.70M
YoY Change 76.56% 171.02% 331.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Trading Symbol
TradingSymbol
GOSS
CY2019 dei Entity Registrant Name
EntityRegistrantName
GOSSAMER BIO, INC.
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001728117
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
319000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-147030000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6771000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-22.59
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9160888
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
947800000
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66336562
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity File Number
EntityFileNumber
001-38796
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5461709
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
3013 Science Park Road
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2019 dei City Area Code
CityAreaCode
858
CY2019 dei Local Phone Number
LocalPhoneNumber
684-1300
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135089000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105219000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
266740000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
123439000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7488000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3095000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
409317000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
231953000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5425000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10303000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1559000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4273000
CY2019Q4 us-gaap Assets
Assets
426604000
CY2018Q4 us-gaap Assets
Assets
239419000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
956000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2182000
CY2019Q4 goss Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
19258000
CY2018Q4 goss Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
10653000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16709000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7568000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36923000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20403000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28459000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8737000
CY2018Q4 goss Accrued Liabilities Non Current
AccruedLiabilitiesNonCurrent
718000
CY2019Q4 us-gaap Liabilities
Liabilities
74119000
CY2018Q4 us-gaap Liabilities
Liabilities
21121000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2019 us-gaap Operating Expenses
OperatingExpenses
186139000
CY2018 us-gaap Operating Expenses
OperatingExpenses
148993000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-186139000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-148993000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-6653000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
686390000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33853000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-334170000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153863000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
258000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-61000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
352485000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-120069000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
426604000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239419000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
49160177
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66284003
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15533450
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61635477
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8051418
CY2019 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
143403000
CY2018 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
55283000
CY2017 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
891000
CY2019 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3600000
CY2018 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
49659000
CY2017 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
5500000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39136000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44051000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
262000
CY2017 us-gaap Operating Expenses
OperatingExpenses
6653000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5832000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2024000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-118000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-180307000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-146969000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-6771000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
331000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-61000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-179988000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.29
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54740170
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6504871
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-123000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-6862000
CY2018 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2875000
CY2018 goss Stock Issued During Period Value Vesting Of Restricted Stock
StockIssuedDuringPeriodValueVestingOfRestrictedStock
1000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30947000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
291311000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
338367000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2045000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20819000
CY2019 us-gaap Profit Loss
ProfitLoss
-180307000
CY2018 us-gaap Profit Loss
ProfitLoss
-146969000
CY2017 us-gaap Profit Loss
ProfitLoss
-6771000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
20819000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1475000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
119000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
917000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
297000
CY2018 goss Acquisition Of In Process Research And Development Through Issuance Of Stock
AcquisitionOfInProcessResearchAndDevelopmentThroughIssuanceOfStock
19284000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
30947000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
32000
CY2019 goss In Process Research And Development Expenses
InProcessResearchAndDevelopmentExpenses
3600000
CY2018 goss In Process Research And Development Expenses
InProcessResearchAndDevelopmentExpenses
49659000
CY2019 goss Amortization Of Operating Lease Right Of Use Assets
AmortizationOfOperatingLeaseRightOfUseAssets
2172000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
237000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2364000
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
28000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4393000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2827000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
130000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2714000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
584000
CY2019 goss Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
2108000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1399000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2085000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1521000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5938000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
824000
CY2019 goss Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
8605000
CY2018 goss Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
10527000
CY2017 goss Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
126000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5180000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-117000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
117000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-144834000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51044000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5745000
CY2019 goss Payments For Proceeds From Research And Development Asset Acquisitions
PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
3600000
CY2018 goss Payments For Proceeds From Research And Development Asset Acquisitions
PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
17721000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
499079000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
123500000
CY2019 goss Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
328000000
CY2019 goss Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
30501000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2966000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3490000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-147144000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144711000
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6000000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
291311000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
28222000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2045000
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
40000
CY2018 goss Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
2144000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
321578000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
300859000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6000000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29600000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
105104000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
255000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105419000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135089000
CY2018 goss Issuance Of Convertible Preferred Stock To Convert Debt And Accrued Interest
IssuanceOfConvertiblePreferredStockToConvertDebtAndAccruedInterest
6124000
CY2018 goss Unpaid Deferred Offering Costs Net
UnpaidDeferredOfferingCostsNet
1545000
CY2019 goss Right Of Use Assets Obtained In Exchange For Lease Liabilities
RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
12458000
CY2019 goss Noncash Financing And Investing Conversions Of Convertible Preferred Stock To Common Stock
NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock
338367000
CY2019 goss Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax
NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax
331000
CY2018 goss Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax
NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax
-61000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
183000
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1778000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accrued research and development expenses, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates. </p>
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10000000
CY2019Q4 goss Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
1337000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2100000
CY2018Q4 goss Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
665000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9282000
goss Funds Raised Through Preferred Equity Financing Convertible Note Financings And Completed Initial Public Offering
FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering
601300000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4102000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2354000
CY2019Q4 goss Accrued In Process Research And Development Current
AccruedInProcessResearchAndDevelopmentCurrent
1600000
CY2019Q4 goss Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
173000
CY2018Q4 goss Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
722000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
10000000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1126000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
769000
CY2019Q4 goss Accrued Legal Fees Current
AccruedLegalFeesCurrent
837000
CY2018Q4 goss Accrued Legal Fees Current
AccruedLegalFeesCurrent
1310000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
30049000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
180307000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6771000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
266465000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
295000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
146969000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4167000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
138342000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
266740000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
18700000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
237449000
CY2019Q4 goss Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
29291000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1541000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
28459000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5833000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
116920000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6771000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
41965000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
41000000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43626000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14442000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
306000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
9196000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1131000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
6597000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
6267000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1588000
CY2019Q4 goss Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
2329000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1476000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
834000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1388000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
383000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
154000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64995000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22828000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1895000
CY2019Q4 goss Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
2164000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
57000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
16000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1317
CY2018Q4 goss Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1057000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2221000
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0573
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1073000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62774000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21755000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1895000
CY2019 goss Federal Research And Development Credits Expiration Year Start
FederalResearchAndDevelopmentCreditsExpirationYearStart
2038
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2212
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2797
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.1185
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0381
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0077
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0184
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0174
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0260
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.0392
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0085
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0034
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0009
CY2019 goss Tax Cuts And Jobs Act Of2017 Decrease In Deferred Tax Asset Due To Transition Tax
TaxCutsAndJobsActOf2017DecreaseInDeferredTaxAssetDueToTransitionTax
800000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
408000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2346000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
408000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2754000
CY2019Q4 goss Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
2600000
CY2019 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2019Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
4648526
CY2018Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
7482032
CY2017Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
1305421
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5143551
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
36222
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5107329
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4194624
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
419593
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
344300
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8538060
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1215471
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.49
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.85
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.51
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.11
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.87
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.64
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.67
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.25
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y8M12D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16343000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35385000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
10183000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20819000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30947000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6639000
CY2019 goss Non Cancelable Operating Sublease Expiration Date For Expansion Space Leased
NonCancelableOperatingSubleaseExpirationDateForExpansionSpaceLeased
2022-12
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3490000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1214000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
297000
CY2019 us-gaap Depreciation
Depreciation
900000
CY2018 us-gaap Depreciation
Depreciation
300000
CY2017 us-gaap Depreciation
Depreciation
0
CY2019 goss Non Cancelable Operating Sublease Expiration Date For Initial Lease Space
NonCancelableOperatingSubleaseExpirationDateForInitialLeaseSpace
2025-01
CY2019 us-gaap Lessee Operating Sublease Existence Of Option To Extend
LesseeOperatingSubleaseExistenceOfOptionToExtend
true
CY2019 us-gaap Lessee Operating Sublease Option To Extend
LesseeOperatingSubleaseOptionToExtend
options to extend for the entire premises through October 2028
CY2019 goss Operating Sublease Annual Increase Percentage For Base Rent
OperatingSubleaseAnnualIncreasePercentageForBaseRent
0.03
CY2019Q4 goss Permanent Monthly Base Rent
PermanentMonthlyBaseRent
63425
CY2019Q4 goss Temporary Monthly Base Rent
TemporaryMonthlyBaseRent
28745
CY2019Q4 goss Period For Which Lease Of Permanent Space Can Be Extended
PeriodForWhichLeaseOfPermanentSpaceCanBeExtended
P12M
CY2019Q4 goss Annual Increase Percentage For Lease Charges
AnnualIncreasePercentageForLeaseCharges
0.03
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
3011000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
133000
CY2019 us-gaap Lease Cost
LeaseCost
3144000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
3000000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3038000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3127000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3220000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1694000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1745000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12824000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1733000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11091000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2944000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3035000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3123000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3216000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1690000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1741000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15749000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3100000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
0
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34017000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-46349000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-49986000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-55787000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-32611000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-44498000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-48500000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-54698000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.89
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-26126000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-33036000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50024000
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.92
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-38794000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.03
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.31
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.52
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-39807000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-26037000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-32729000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-49409000

Files In Submission

Name View Source Status
0001564590-20-012323-index-headers.html Edgar Link pending
0001564590-20-012323-index.html Edgar Link pending
0001564590-20-012323.txt Edgar Link pending
0001564590-20-012323-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmwvvzuraj1z000001.jpg Edgar Link pending
gmwvvzuraj1z000002.jpg Edgar Link pending
gmwvvzuraj1z000003.jpg Edgar Link pending
gmwvvzuraj1z000004.jpg Edgar Link pending
gmwvvzuraj1z000005.jpg Edgar Link pending
gmwvvzuraj1z000006.jpg Edgar Link pending
gmwvvzuraj1z000007.jpg Edgar Link pending
gmwvvzuraj1z000008.jpg Edgar Link pending
goss-10k_20191231.htm Edgar Link pending
goss-20191231.xml Edgar Link completed
goss-20191231.xsd Edgar Link pending
goss-20191231_cal.xml Edgar Link unprocessable
goss-20191231_def.xml Edgar Link unprocessable
goss-20191231_lab.xml Edgar Link unprocessable
goss-20191231_pre.xml Edgar Link unprocessable
goss-ex211_11.htm Edgar Link pending
goss-ex231_10.htm Edgar Link pending
goss-ex311_8.htm Edgar Link pending
goss-ex312_9.htm Edgar Link pending
goss-ex321_6.htm Edgar Link pending
goss-ex322_7.htm Edgar Link pending
goss-ex43_366.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending